Results 81 to 90 of about 49,575 (291)

Spatially fractionated radiotherapy versus conventional radiotherapy in the treatment of soft tissue sarcoma: A multicenter, prospective, phase II, randomized controlled clinical trial protocol

open access: yesPrecision Radiation Oncology, EarlyView.
The first randomized controlled trial comparing spatially fractionated radiotherapy (SFRT) with conventional radiotherapy (CRT) for soft tissue sarcoma (STS) will evaluate efficacy and safety, offering critical evidence to optimize treatment strategies.
Peng Shang   +4 more
wiley   +1 more source

Stereotactic body radiotherapy takes on Lung Oligometastases: Latest breakthroughs

open access: yesPrecision Radiation Oncology
Lung oligometastases represent an intermediate state of cancer dissemination between localized and widespread metastases. Stereotactic body radiation therapy (SBRT) has emerged as an effective treatment option, with an efficacy comparable to that of ...
Xin Liu   +7 more
doaj   +1 more source

Stereotactic Body Radiotherapy for Central Lung Tumors [PDF]

open access: yesJournal of Thoracic Oncology, 2012
Patients with centrally located lung tumors have been reported to have a higher risk of toxicity when treated with stereotactic body radiotherapy (SBRT) compared with patients with peripheral tumors. The optimal SBRT fractionation schedule for treatment of central tumors is unknown.
Rowe, Bryan P.   +5 more
openaire   +2 more sources

A new perspective on cancer treatment: the interaction and application prospect between ICIs and radiotherapy

open access: yesPrecision Radiation Oncology, EarlyView.
The combination of immune checkpoint inhibitors (ICIs) and radiotherapy synergistically enhances efficacy through an “antigen release‐immune activation” closed‐loop mechanism, significantly improving outcomes in solid tumors (e.g., lung cancer, melanoma).
Guiling Song   +5 more
wiley   +1 more source

Dose Prescription Methods in Stereotactic Body Radiotherapy for Small Peripheral Lung Tumors: Approaches Based on the Gross Tumor Volume Are Superior to Prescribing a Dose That Covers 95% of the Planning Target Volume

open access: yesTechnology in Cancer Research & Treatment, 2020
Background and Purpose: We aimed to validate the usefulness of prescriptions based on gross tumor volume for stereotactic body radiotherapy for small peripheral lung tumors.
Takafumi Komiyama MD, PhD   +17 more
doaj   +1 more source

Establishment and Comparative Analysis of Radiation‐Induced Liver Disease in Normal and Fibrotic Rat Models

open access: yesPrecision Radiation Oncology, EarlyView.
This study successfully established two novel rat models of radiation‐induced liver disease (RILD), one in healthy livers and the other in TAA‐induced fibrotic livers, providing valuable insights into the combined effects of radiation and pre‐existing fibrosis.
Yanting Jiang   +9 more
wiley   +1 more source

Full Issue: Volume 13, Issue 1 - Winter 2018 [PDF]

open access: yes, 2018
Full Issue: Volume 13, Issue 1 - Winter ...

core   +1 more source

Radiomics-Based Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy [PDF]

open access: yes, 2020
(1) Background: Radiomics use high-throughput mining of medical imaging data to extract unique information and predict tumor behavior. Currently available clinical prediction models poorly predict treatment outcomes in pancreatic adenocarcinoma ...
Baine, Michael   +11 more
core   +1 more source

Impact of use of optical surface imaging on initial patient setup for stereotactic body radiotherapy treatments [PDF]

open access: yes, 2019
Purpose To evaluate the effectiveness of surface image guidance (SG) for pre‐imaging setup of stereotactic body radiotherapy (SBRT) patients, and to investigate the impact of SG reference surface selection on this process.
Al‐Hallaq HA   +3 more
core   +2 more sources

Recent Progress in the Development of Metal‐Based Radiosensitizations for Cancer Therapy: A Review

open access: yesRare Metals, EarlyView.
ABSTRACT Radiotherapy (RT) remains an indispensable means in cancer treatment; however, its therapeutic efficacy is often limited by tumor radioresistance and side effect of damage to healthy tissue. The advances in nanotechnology have propelled metal radiosensitizers to forefront of precision medicine.
Xiao‐Xia Wu   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy